Company | Date | Price Target | Rating | Analyst |
---|---|---|---|---|
7/23/2024 | $375.00 | Buy | Vertical Research | |
6/13/2024 | $305.00 | Underperform → Neutral | Exane BNP Paribas | |
4/8/2024 | $337.00 | Peer Perform → Outperform | Wolfe Research | |
4/2/2024 | $292.00 | Equal Weight | Barclays | |
3/14/2024 | $300.00 | Hold | Truist | |
2/26/2024 | $23.00 | Market Perform | Leerink Partners | |
2/20/2024 | Hold → Reduce | HSBC Securities | ||
1/3/2024 | $21.00 | Underweight | Barclays |
Names Tracey Koller as Chief Merchandising Officer and Sharmila Sudhakar as Group Vice President and Head of Digital Commerce Walgreens, the leading independent retail pharmacy and healthcare provider, today announced two key leadership appointments: Tracey Koller, senior vice president and chief merchandising officer, and Sharmila Sudhakar, group vice president and head of Walgreens digital commerce. The company believes these new appointments will significantly contribute to its efforts with regard to the turnaround of the business as the company focuses on enhancing the front of store and omnichannel experience for its customers while driving in-store efficiencies. This press release
NEW YORK, July 12, 2024 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced that Super Micro Computer Inc. (NASDAQ:SMCI), will become a component of the Nasdaq-100 Index® (NASDAQ:NDX) and the Nasdaq-100 Equal Weighted™ Index (NASDAQ:NDXE) prior to market open on Monday, July 22, 2024. Super Micro Computer Inc. will replace Walgreens Boots Alliance Inc. (NASDAQ:WBA) in the Nasdaq-100 Index® and the Nasdaq-100 Equal Weighted Index. Walgreens Boots Alliance Inc. will also be removed from the Nasdaq-100 Ex-Tech Sector™ Index (NASDAQ:NDXX), the Nasdaq-100 ESG™ Index (NASDAQ:NDXESG), and the Nasdaq-100 Sustainable ESG Select™ Index (NASDAQ:NDXSES) on the same date. Super Micro Computer Inc
Dr. Shrank brings extensive healthcare experience, business leadership and clinical expertise to WBA board as the company undergoes strategic turnaround Walgreens Boots Alliance, Inc. (NASDAQ:WBA) today announced the appointment of William H. Shrank, M.D., to the company's board of directors. Dr. Shrank is globally recognized for his leadership and expertise in healthcare strategy, policy and population health. He joins the WBA board at an important time as the company strengthens its business. Currently, Dr. Shrank is a venture partner with the Bio + Health Team of Andreesen Horowitz, a private venture capital firm, a role he has held since January 2023. He previously served in a numbe
4 - ZEBRA TECHNOLOGIES CORP (0000877212) (Issuer)
3 - Walgreens Boots Alliance, Inc. (0001618921) (Issuer)
4 - ZEBRA TECHNOLOGIES CORP (0000877212) (Issuer)
SC 13D/A - Walgreens Boots Alliance, Inc. (0001618921) (Filed by)
SC 13G/A - ZEBRA TECHNOLOGIES CORP (0000877212) (Subject)
SC 13G/A - Walgreens Boots Alliance, Inc. (0001618921) (Subject)
N-PX - Walgreens Boots Alliance, Inc. (0001618921) (Filer)
13F-HR - Walgreens Boots Alliance, Inc. (0001618921) (Filer)
8-K - Walgreens Boots Alliance, Inc. (0001618921) (Filer)
For Immediate Release: September 12, 2023 The U.S. Food and Drug Administration has issued warning letters to eight companies for manufacturing or marketing unapproved ophthalmic drug products in violation of federal law. These warning letters are part of the agency’s ongoing effort to protect Americans from potentially harmful ophthalmic products. Eye products addressed in the eight warning letters are illegal
4 - Walgreens Boots Alliance, Inc. (0001618921) (Issuer)
4 - Walgreens Boots Alliance, Inc. (0001618921) (Issuer)
4 - Walgreens Boots Alliance, Inc. (0001618921) (Issuer)
Vertical Research initiated coverage of Zebra Tech with a rating of Buy and set a new price target of $375.00
Exane BNP Paribas upgraded Zebra Tech from Underperform to Neutral and set a new price target of $305.00
Wolfe Research upgraded Zebra Tech from Peer Perform to Outperform and set a new price target of $337.00
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) will release its fourth quarter and 2024 fiscal year-end results at 7 a.m. ET on Tuesday, October 15, 2024, followed by a one-hour conference call with WBA management beginning at 8:30 a.m. ET. The conference call will be simulcast through the WBA investor relations website at: http://investor.walgreensbootsalliance.com. A replay will be archived on the website for 12 months after the call. About Walgreens Boots Alliance Walgreens Boots Alliance (NASDAQ:WBA) is an integrated healthcare, pharmacy and retail leader serving millions of customers and patients every day, with a 170-year heritage of caring for communities. A trusted, global innovato
NOTE TO EDITORS: The Following is an Investment Opinion Issued by Spruce Point Capital Management Believes That Zebra Is Downplaying Competitive Pressures Across Its Core Hardware, Services and Software Offerings, and May Be Embellishing Market Leadership Claims Highlights How Zebra is Not Adequately Addressing a Variety of Trends and Factors Working Against the Company Outlines Why Zebra's $2.1 Billion Levered Acquisition Spree and Venture Investments – Which Expanded Its Offerings into Analytics, Robotics, and Machine Vision – Should be Characterized as Failures Expresses Concerns About Multiple Accounting and Financial Reporting Choices Made by Zebra Given That It Describes Its C
Second-Quarter Financial Highlights Net sales of $1,217 million; year-over-year increase of 0.2% Net income of $113 million and net income per diluted share of $2.17 Non-GAAP diluted EPS decreased year-over-year to $3.18 Adjusted EBITDA decreased year-over-year to $250 million On track with $120 million annualized net expense savings from our Exit and Restructuring plans Zebra Technologies Corporation (NASDAQ:ZBRA), an innovator at the edge of the enterprise with solutions and partners that enable businesses to gain a performance edge, today announced results for the second quarter ended June 29, 2024. "Our teams executed well during the quarter, enabling us to deliver s
Company will close nearly all of its stores and pharmacies for the second consecutive year to give team members time with their loved ones; 24-Hour locations will remain open to meet customer and patient healthcare needs All Walgreens locations will be open on Christmas Day and New Year's Day On Thanksgiving Day (November 28), most Walgreens locations will be closed, except for 500 Walgreens 24-hour locations, and 300 pharmacies within those locations, that will remain open on Thanksgiving to help meet the healthcare needs of our customers. This is the second year in a row Walgreens has chosen to close its doors on Thanksgiving to allow team members to spend more time with loved ones. Thi
Company is recognized on the General Excellence list, reflecting its culture of innovation Zebra Technologies Corporation (NASDAQ:ZBRA), a leading digital solution provider enabling businesses to intelligently connect data, assets, and people, today announced it ranked #51 on Fast Company's sixth annual list of the 100 Best Workplaces for Innovators as well as its 2024 General Excellence list. This recognition reflects the company's commitment to building a strong, innovative, and inclusive culture at every level of the organization. Zebra is a community of innovators whose purpose is to create new ways of working to make everyday life better for organizations, their employees, and those
MOUNT PROSPECT, Ill., Sept. 10, 2024 /PRNewswire/ -- Walgreens has joined Pulse by NABP™, the new digital platform from National Association of Boards of Pharmacy® (NABP®) that will bring visibility to the drug supply chain and protect patients from counterfeit or substandard prescription medications. Walgreens will use Pulse to assist with Drug Supply Chain Security Act (DSCSA) compliance and to help ensure its prescription medication suppliers are appropriately licensed. Walgreens will use Pulse to assist with DSCSA compliance and protect patients from counterfeit prescripti
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Goldman Sachs cut the price target for SunPower Corporation (NASDAQ:SPWR) from $2 to $0.5. Goldman Sachs analyst Brian Lee maintained a Sell rating. SunPower shares gained 5.4% to close at $0.7158 on Monday. See how other analysts view this stock. Piper Sandler increased the price target for Cathay General Bancorp (NASDAQ:CATY) from $32 to $36. Piper Sandler analyst Matthew Clark maintained an Underweight rating. Cathay General Bancorp shares gained 2.4% to close at $43.02 on Monday. See how other
Analysts' ratings for Walgreens Boots Alliance (NASDAQ:WBA) over the last quarter vary from bullish to bearish, as provided by 14 analysts. In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 1 6 6 0 Last 30D 0 0 0 1 0 1M Ago 1 1 5 4 0 2M Ago 0 0 1 1 0 3M Ago 0 0 0 0 0 Analysts have recently evaluated Walgreens Boots Alliance and provided 12-month price targets. The average target is $13.86, accompanied by a high estimate of $22.00 and a low estimate of $7.00. A decline of 30.46% fro
Barclays analyst Steve Valiquette maintains Walgreens Boots Alliance (NASDAQ:WBA) with a Underweight and lowers the price target from $11 to $7.